Mostrar el registro sencillo del ítem
dc.contributor.author
Whittaker, Danielle E.
dc.contributor.author
Riegman, Kimberley L. H.
dc.contributor.author
Kasah, Sahrunizam
dc.contributor.author
Mohan, Conor
dc.contributor.author
Yu, Tian
dc.contributor.author
Sala, Blanca Pijuan
dc.contributor.author
Hebaishi, Husam
dc.contributor.author
Caruso, Angela
dc.contributor.author
Marques, Ana Claudia
dc.contributor.author
Michetti, Caterina
dc.contributor.author
Sanz Smachetti, María Eugenia

dc.contributor.author
Shah, Apar
dc.contributor.author
Sabbioni, Mara
dc.contributor.author
Kulhanci, Omer
dc.contributor.author
Tee, Wee-Wei
dc.contributor.author
Reinberg, Danny
dc.contributor.author
Scattoni, Maria Luisa
dc.contributor.author
Volk, Holger
dc.contributor.author
McGonnell, Imelda
dc.contributor.author
Wardle, Fiona C.
dc.contributor.author
Fernandez, Cathy
dc.contributor.author
Basson, Albert
dc.date.available
2017-07-10T15:06:15Z
dc.date.issued
2017-03-01
dc.identifier.citation
Whittaker, Danielle E.; Riegman, Kimberley L. H.; Kasah, Sahrunizam; Mohan, Conor; Yu, Tian; et al.; The chromatin remodeling factor CHD7 controls cerebellar development by regulating reelin expression; Amer Soc Clinical Investigation Inc; Journal Of Clinical Investigation; 127; 3; 1-3-2017; 874-887
dc.identifier.issn
0021-9738
dc.identifier.uri
http://hdl.handle.net/11336/19973
dc.description.abstract
The mechanisms underlying the neurodevelopmental deficits associated with CHARGE syndrome, which include cerebellar hypoplasia, developmental delay, coordination problems, and autistic features, have not been identified. CHARGE syndrome has been associated with mutations in the gene encoding the ATP-dependent chromatin remodeler CHD7. CHD7 is expressed in neural stem and progenitor cells, but its role in neurogenesis during brain development remains unknown. Here we have shown that deletion of Chd7 from cerebellar granule cell progenitors (GCps) results in reduced GCp proliferation, cerebellar hypoplasia, developmental delay, and motor deficits in mice. Genome-wide expression profiling revealed downregulated expression of the gene encoding the glycoprotein reelin (Reln) in Chd7-deficient GCps. Recessive RELN mutations have been associated with severe cerebellar hypoplasia in humans. We found molecular and genetic evidence that reductions in Reln expression contribute to GCp proliferative defects and cerebellar hypoplasia in GCp-specific Chd7 mouse mutants. Finally, we showed that CHD7 is necessary for maintaining an open, accessible chromatin state at the Reln locus. Taken together, this study shows that Reln gene expression is regulated by chromatin remodeling, identifies CHD7 as a previously unrecognized upstream regulator of Reln, and provides direct in vivo evidence that a mammalian CHD protein can control brain development by modulating chromatin accessibility in neuronal progenitors.
dc.format
application/pdf
dc.language.iso
eng
dc.publisher
Amer Soc Clinical Investigation Inc

dc.rights
info:eu-repo/semantics/openAccess
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.subject
Chd7
dc.subject
Cerebellar Development
dc.subject
Reelin Expresion
dc.subject.classification
Neurociencias

dc.subject.classification
Medicina Básica

dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD

dc.title
The chromatin remodeling factor CHD7 controls cerebellar development by regulating reelin expression
dc.type
info:eu-repo/semantics/article
dc.type
info:ar-repo/semantics/artículo
dc.type
info:eu-repo/semantics/publishedVersion
dc.date.updated
2017-07-10T13:11:27Z
dc.journal.volume
127
dc.journal.number
3
dc.journal.pagination
874-887
dc.journal.pais
Estados Unidos

dc.journal.ciudad
Ann Arbor
dc.description.fil
Fil: Whittaker, Danielle E.. Royal Veterinary College University Of London; . King’s College London. Department of Craniofacial Development and Stem Cell Biology. Guy’s Hospital Tower Wing; Reino Unido
dc.description.fil
Fil: Riegman, Kimberley L. H.. King’s College London. Department of Craniofacial Development and Stem Cell Biology. Guy’s Hospital Tower Wing; Reino Unido
dc.description.fil
Fil: Kasah, Sahrunizam. King’s College London. Department of Craniofacial Development and Stem Cell Biology. Guy’s Hospital Tower Wing; Reino Unido
dc.description.fil
Fil: Mohan, Conor. King’s College London. Department of Craniofacial Development and Stem Cell Biology. Guy’s Hospital Tower Wing; Reino Unido
dc.description.fil
Fil: Yu, Tian. King’s College London. Department of Craniofacial Development and Stem Cell Biology. Guy’s Hospital Tower Wing; Reino Unido
dc.description.fil
Fil: Sala, Blanca Pijuan. King’s College London. Department of Craniofacial Development and Stem Cell Biology. Guy’s Hospital Tower Wing; Reino Unido
dc.description.fil
Fil: Hebaishi, Husam. University College London; Estados Unidos
dc.description.fil
Fil: Caruso, Angela. Istituto Superiore di Sanità. Department of Cell Biology and Neuroscience. Neurotoxicology and Neuroendocrinology Section; Italia
dc.description.fil
Fil: Marques, Ana Claudia. University of Oxford. Department of Physiology, Anatomy and Genetics; Reino Unido
dc.description.fil
Fil: Michetti, Caterina. Istituto Superiore di Sanità. Department of Cell Biology and Neuroscience. Neurotoxicology and Neuroendocrinology Section; Italia
dc.description.fil
Fil: Sanz Smachetti, María Eugenia. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Mar del Plata. Instituto de Investigaciones En Biodiversidad y Biotecnología; Argentina. Fundación para Investigaciones Biológicas Aplicadas; Argentina
dc.description.fil
Fil: Shah, Apar. King’s College London. Department of Craniofacial Development and Stem Cell Biology. Guy’s Hospital Tower Wing; Reino Unido
dc.description.fil
Fil: Sabbioni, Mara. Istituto Superiore di Sanità. Department of Cell Biology and Neuroscience. Neurotoxicology and Neuroendocrinology Section; Italia
dc.description.fil
Fil: Kulhanci, Omer. King’s College London, London, United Kingdom. Institute of Psychiatry, Psychology & Neuroscience. MRC Social, Genetic & Developmental Psychiatry Centre; Reino Unido
dc.description.fil
Fil: Tee, Wee-Wei. New York University School of Medicine. Department of Molecular Pharmacology and Biochemistry. Howard Hughes Medical Institute; Estados Unidos
dc.description.fil
Fil: Reinberg, Danny. New York University School of Medicine. Department of Molecular Pharmacology and Biochemistry. Howard Hughes Medical Institute; Estados Unidos
dc.description.fil
Fil: Scattoni, Maria Luisa. Istituto Superiore di Sanità. Department of Cell Biology and Neuroscience. Neurotoxicology and Neuroendocrinology Section; Italia
dc.description.fil
Fil: Volk, Holger. Royal Veterinary College University Of London; Reino Unido
dc.description.fil
Fil: McGonnell, Imelda. Royal Veterinary College University Of London; Reino Unido
dc.description.fil
Fil: Wardle, Fiona C.. King’s College London. Randall Division; Reino Unido
dc.description.fil
Fil: Fernandez, Cathy. King’s College London, London, United Kingdom. Psychology & Neuroscience; Reino Unido
dc.description.fil
Fil: Basson, Albert. King’s College London. Department of Craniofacial Development and Stem Cell Biology. Guy’s Hospital Tower Wing; Reino Unido
dc.journal.title
Journal Of Clinical Investigation

dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1172/JCI83408
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://www.jci.org/articles/view/83408
Archivos asociados